Terms: = Lymphoma AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Treatment
12 results:
1. erbb4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.
Arribas AJ; Napoli S; Cascione L; Barnabei L; Sartori G; Cannas E; Gaudio E; Tarantelli C; Mensah AA; Spriano F; Zucchetto A; Rossi FM; Rinaldi A; Castro de Moura M; Jovic S; Bordone Pittau R; Stathis A; Stussi G; Gattei V; Brown JR; Esteller M; Zucca E; Rossi D; Bertoni F
Mol Cancer Ther; 2024 Mar; 23(3):368-380. PubMed ID: 38052765
[TBL] [Abstract] [Full Text] [Related]
2. Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
Zhang C; Mou B; Xu J; Wang J; Liu Q; Yang Y; Tang W; Zhong X; Xu C
Br J Haematol; 2023 Dec; 203(5):807-819. PubMed ID: 37646306
[TBL] [Abstract] [Full Text] [Related]
3. [Fertility preservation in female cancer patients.].
Vesztergom D; Székely B; Hegyi B; Masszi A; Pintér T; Csákó B; Kenessey I; Rubovszky G; Novák Z
Orv Hetil; 2023 Jul; 164(29):1134-1145. PubMed ID: 37481767
[TBL] [Abstract] [Full Text] [Related]
4. Life after Cleavage: The Story of a β-Retroviral (MMTV) Signal Peptide-From Murine lymphoma to Human Breast Cancer.
Hochman J; Braitbard O
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366533
[TBL] [Abstract] [Full Text] [Related]
5. Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study.
Tan DS; Thomas M; Kim DW; Szpakowski S; Urban P; Mehra R; Chow LQM; Sharma S; Solomon BJ; Felip E; Camidge DR; Vansteenkiste J; Petruzzelli L; Pantano S; Shaw AT
Lung Cancer; 2022 Jan; 163():7-13. PubMed ID: 34890832
[TBL] [Abstract] [Full Text] [Related]
6. The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapy.
Tkacz J; Garcia J; Gitlin M; McMorrow D; Snyder S; Bonafede M; Chung KC; Maziarz RT
Leuk Lymphoma; 2020 Jul; 61(7):1601-1609. PubMed ID: 32270727
[TBL] [Abstract] [Full Text] [Related]
7. Lorlatinib treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer.
Redaelli S; Ceccon M; Zappa M; Sharma GG; Mastini C; Mauri M; Nigoghossian M; Massimino L; Cordani N; Farina F; Piazza R; Gambacorti-Passerini C; Mologni L
Cancer Res; 2018 Dec; 78(24):6866-6880. PubMed ID: 30322862
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract] [Full Text] [Related]
9. Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma.
Kim JW; Lee HJ; Yi HG; Kim BS; Bang SM; Kim JS; Kim I; Yoon SS; Lee JS; Kim CS; Park S; Kim BK
Am J Hematol; 2012 May; 87(5):479-83. PubMed ID: 22388671
[TBL] [Abstract] [Full Text] [Related]
10. The role of neuregulin4 and her4 in gastrointestinal malignant lymphoma.
Ebi M; Kataoka H; Shimura T; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Tsukamoto H; Ozeki K; Tanida S; Kamiya T; Inagaki H; Joh T
Mol Med Rep; 2011; 4(6):1151-5. PubMed ID: 21805036
[TBL] [Abstract] [Full Text] [Related]
11. VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms.
Roorda BD; Ter Elst A; Scherpen FJ; Meeuwsen-de Boer TG; Kamps WA; de Bont ES
Eur J Cancer; 2010 Mar; 46(5):974-82. PubMed ID: 20064707
[TBL] [Abstract] [Full Text] [Related]
12. [Adverse reactions associated with the use of L-asparaginase during therapy of patients with nB non-Hodgkin's lymphoma. Report of the Polish Paediatric LeuKaemia/lymphoma Study Group].
Wróbel G; Dobaczewski G; Kazanowska B; Bogusławska-Jaworska J; Balwierz W; Balcerska A; Bubała H; Dluzniewska A; Kołecki P; Kowalczyk J; Kurylak A; Maciejka-Kapuscinska L; Matysiak M; Rokicka-Milewska R; Sońta-Jakimczyk D; Sopyło B; Stefaniak MJ; Stefańska K; Stańczak E; Wysocki M
Med Wieku Rozwoj; 2000; 4(1 Suppl 2):67-72. PubMed ID: 12021464
[TBL] [Abstract] [Full Text] [Related]
